Insider Transactions in Q3 2022 at Inari Medical, Inc. (NARI)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 15
2022
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.22%
|
$560,000
$80.25 P/Share
|
|
Sep 09
2022
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
13,692
-1.27%
|
$1,040,592
$76.71 P/Share
|
|
Sep 08
2022
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
16,308
-4.3%
|
$1,223,100
$75.12 P/Share
|
|
Sep 07
2022
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
30,000
-1.88%
|
$2,130,000
$71.25 P/Share
|
|
Sep 07
2022
|
William Hoffman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+6.84%
|
$0
$0.43 P/Share
|
|
Sep 06
2022
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
5,000
-3.68%
|
$350,000
$70.0 P/Share
|
|
Aug 29
2022
|
William Hoffman Director |
SELL
Bona fide gift
|
Direct |
139,998
-26.98%
|
-
|
|
Aug 15
2022
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.07%
|
$567,000
$81.46 P/Share
|
|
Aug 15
2022
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,500
-2.24%
|
$607,500
$81.85 P/Share
|
|
Aug 15
2022
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+7.99%
|
$0
$0.46 P/Share
|
|
Aug 12
2022
|
Donald B Milder Director |
SELL
Bona fide gift
|
Indirect |
210,000
-6.13%
|
-
|
|
Aug 05
2022
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
30,000
-1.11%
|
$2,460,000
$83.0 P/Share
|
|
Aug 05
2022
|
William Hoffman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+5.18%
|
$0
$0.43 P/Share
|
|
Aug 02
2022
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
21,000
-0.1%
|
$1,680,000
$80.74 P/Share
|
|
Aug 01
2022
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
5,000
-0.89%
|
$390,000
$78.47 P/Share
|
|
Jul 18
2022
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
5,275
-1.01%
|
$395,625
$75.29 P/Share
|
|
Jul 15
2022
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,500
-2.95%
|
$540,000
$72.73 P/Share
|
|
Jul 15
2022
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+7.99%
|
$0
$0.46 P/Share
|
|
Jul 08
2022
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
11,237
-1.05%
|
$842,775
$75.58 P/Share
|
|
Jul 07
2022
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
13,488
-2.46%
|
$1,011,600
$75.08 P/Share
|
|
Jul 06
2022
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
30,000
-1.75%
|
$2,160,000
$72.5 P/Share
|
|
Jul 06
2022
|
William Hoffman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+4.93%
|
$0
$0.43 P/Share
|
|
Jul 05
2022
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
5,000
-3.42%
|
$350,000
$70.31 P/Share
|
|
Jul 01
2022
|
Thomas Tu Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
684
-0.32%
|
$46,512
$68.66 P/Share
|
|
Jul 01
2022
|
Andrew Hykes President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
993
-0.34%
|
$67,524
$68.66 P/Share
|
|
Jul 01
2022
|
William Hoffman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,408
-0.13%
|
$95,744
$68.66 P/Share
|
|
Jul 01
2022
|
Hill, Mitch C. Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
663
-0.42%
|
$45,084
$68.66 P/Share
|